SELEXIPAG vs SELPERCATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SELEXIPAG vs SELPERCATINIB: Safety Overview
| Metric | SELEXIPAG | SELPERCATINIB |
|---|---|---|
| Total FAERS Reports | 18,471 | 1,084 |
| Deaths Reported | 3,778 | 160 |
| Death Rate | 20.5% | 14.8% |
| Hospitalizations | 9,394 | 342 |
| Average Patient Age | 58.4 yrs | 63.0 yrs |
| % Female Patients | 71.9% | 56.7% |
| FDA Approval Date | Dec 21, 2015 | Apr 10, 2024 |
| Manufacturer | Zydus Pharmaceuticals (USA) Inc. | Eli Lilly and Company |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |